TORONTO, ONTARIO -- (Marketwire) -- 12/31/09 --
Canadian Orebodies Inc. (TSX VENTURE: CO)(the "Company") is pleased to announce that it has closed on its second and final tranche of a non-brokered private placement (the "Financing") for aggregate gross proceeds of $257,440 through the sale of 540,000 units of securities of the Company (each, a "Unit") at a price of $0.10 per Unit and 1,695,333 "flow-through" units of the Company (each, a "Flow-Through Unit") at a price of $0.12 per Unit
Each Unit is comprised of one common share of the Company (each, a "Common Share") and one-half of one Common Share purchase warrant of the Company (each such whole Common Share purchase warrant, a "Warrant"). Each Warrant entitles the holder thereof to purchase one Common Share for a period of 24 months from the closing of the Financing (the "Closing Date") at an exercise price of $0.20 per Common Share provided, however, that the expiry date of the Warrants may be accelerated, at the option of the Company, if the closing price of the Common Shares on the TSX Venture Exchange or such other exchange, market or trading or quotation facility in Canada exceeds $0.30 for a period of 20 consecutive trading days, commencing any time after the date that is four months and one day after the Closing Date, by giving notice to the holders thereof, in which case the Warrants will expire on the twentieth business day after the date on which such notice is given by the Company
Each Flow-Through Unit is comprised of one Common Share issued on a "flow-through" basis pursuant to the Income Tax Act (Canada) and one-half of one Warrant
The Company paid cash finders' fees in the aggregate amount of $18,995.20 and granted non transferable options (each, a "Finders Option") to purchase an aggregate of up to 203,533 units of the Company (each, a "Finders Unit"). Each Finders Option entitles the holder thereof to purchase one Finders Unit for a period of 24 months from the date of issuance at an exercise price of $0.12. Each Finders Unit will be comprised of one Common Share and one half of one Common Share purchase warrant (each such whole Common Share purchase warrant, a "Finders Unit Warrant"). Each Finders Unit Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of $0.20 per Common Share for a period of 24 months from the Closing Date
The securities issued by the Company in connection with this offering are subject to a statutory hold period which expires on May 1, 2010
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this press release
Contacts: Canadian Orebodies Inc
Gordon McKinnon President & CEO (705) 268-9000 www.canadianorebodies.com

Liked By
Spread the love. Be the first to like this post!
Recent CO News
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 03/03/2023 09:20:52 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/03/2023 07:39:34 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/03/2023 01:01:32 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 12/02/2022 09:07:25 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 10/31/2022 08:03:30 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 10/21/2022 09:15:41 PM
- Global Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman Islands • Business Wire • 09/26/2022 08:07:00 PM
- Global Cord Blood trading halted by NYSE for ‘regulatory concern’ • TipRanks • 09/23/2022 06:07:52 PM
- The Grand Court of the Cayman Islands Granted Blue Ocean’s Application to Appoint Joint Provisional Liquidators for Global Cord Blood Corporation • Business Wire • 09/23/2022 05:52:00 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 08/24/2022 01:02:32 PM
- Annual and Transition Report (foreign Private Issuer) (20-f) • Edgar (US Regulatory) • 08/16/2022 08:26:00 PM
- Global Cord Blood Corporation Files Annual Report on Form 20-F • PR Newswire (US) • 08/16/2022 08:16:00 PM
- Notification That Form 20-f Will Be Submitted Late (nt 20-f) • Edgar (US Regulatory) • 08/02/2022 12:01:19 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 07/06/2022 08:22:26 PM
- Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM • PR Newswire (US) • 07/06/2022 08:16:00 PM
- Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 • PR Newswire (US) • 07/05/2022 08:16:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 06/27/2022 12:02:30 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 06/22/2022 08:01:30 PM
- Global Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for IND • Dow Jones News • 06/17/2022 04:49:00 PM
- Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis • PR Newswire (US) • 06/16/2022 08:20:00 PM
- Shareholders Led by Blue Ocean Announce Successful Results of Extraordinary General Meeting of Global Cord Blood Corporation • Business Wire • 06/16/2022 08:05:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 06/16/2022 12:38:47 PM
- Global Cord Blood Corporation Announces Purported EGM Is Not Validly Convened • PR Newswire (US) • 06/16/2022 12:30:00 PM
- Shareholders of Global Cord Blood Corporation Are Reminded to Comply with the Rules of Conduct When Attending the Extraordinary General Meeting and Exercising Their Voting Rights • Business Wire • 06/15/2022 11:38:00 AM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 06/15/2022 10:41:02 AM
Glucose Health, Inc. Fiscal 2022 Annual Report • GLUC • Mar 23, 2023 3:23 PM
Nextech3D.ai Announces Its AI-Powered SaaS Platform Toggle3D Experiences A +963% Jump in Users in 60-Days Crossing Over 1000 Users • NTAR • Mar 23, 2023 7:07 AM
Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • TMC • Mar 22, 2023 1:44 PM
Fineqia Announces Partnership with Paris Blockchain Week to Accelerate Digital Asset Innovation • FNQQF • Mar 22, 2023 10:03 AM
E-Cite and ClearMarket Launch Nationwide EV Distribution Network Becoming the First All EV Dealership Opening in the Cerritos Auto Square, the World's Largest Automall • VAPR • Mar 22, 2023 9:41 AM
Electromedical Announces $1.36M Net Proceeds from Building Sale to Fund WellnessPro Infinity ™ Launch and Convertible Note Retirement. • EMED • Mar 22, 2023 7:04 AM